Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William B Feldman

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
JAMA|November 13, 2023
Ancillary Product Patents to Extend Biologic Patent LifeRachel Goode, William B Feldman, S Sean Tu
JAMA|February 21, 2022
Switching to Over-the-Counter Availability of Rescue Inhalers for AsthmaWilliam B Feldman, Jerry Avorn, Aaron S Kesselheim
JAMA|September 5, 2024
Seeking a Better Paper Trail of Federal Research FundingLiam Bendicksen, Aaron S Kesselheim, William B Feldman
JAMA|December 14, 2023
Biologic Patent Thickets and Terminal DisclaimersS Sean Tu, Rachel Goode, William B Feldman
Chest|May 7, 2025
Trends in Medicare Spending on Drugs for Pulmonary Arterial Hypertension, 2012-2022Jenny A Shih, Charlie Lee, William B Feldman
Annals of Internal Medicine|December 29, 2025
The Pharmaceutical Industry's Quiet Win in the One Big Beautiful Bill ActShria Bucha, Matthew J Martin, William B Feldman
Stroke|January 21, 2017
Trends in Recruitment Rates for Acute Stroke Trials, 1990-2014William B Feldman, Anthony S Kim, Winston Chiong
JAMA Internal Medicine|December 3, 2019
Potential Medicare Savings on Inhaler Prescriptions Through the Use of Negotiated Prices and a Defined FormularyWilliam B Feldman, Jerry Avorn, Aaron S Kesselheim
Journal of Empirical Research on Human Research Ethics : JERHRE|April 20, 2022
Practicalities of Impracticability: An Interim Review of Randomized Controlled TrialsRoma Dhamanaskar, William B Feldman, Jon F Merz
The New England Journal of Medicine|September 26, 2022
Product Hopping in the Drug Industry - Lessons from AlbuterolOlivier J Wouters, William B Feldman, S Sean Tu
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
JAMA|November 13, 2023
Ancillary Product Patents to Extend Biologic Patent LifeRachel Goode, William B Feldman, S Sean Tu
JAMA|February 21, 2022
Switching to Over-the-Counter Availability of Rescue Inhalers for AsthmaWilliam B Feldman, Jerry Avorn, Aaron S Kesselheim
JAMA|September 5, 2024
Seeking a Better Paper Trail of Federal Research FundingLiam Bendicksen, Aaron S Kesselheim, William B Feldman
JAMA|December 14, 2023
Biologic Patent Thickets and Terminal DisclaimersS Sean Tu, Rachel Goode, William B Feldman
Chest|May 7, 2025
Trends in Medicare Spending on Drugs for Pulmonary Arterial Hypertension, 2012-2022Jenny A Shih, Charlie Lee, William B Feldman
Annals of Internal Medicine|December 29, 2025
The Pharmaceutical Industry's Quiet Win in the One Big Beautiful Bill ActShria Bucha, Matthew J Martin, William B Feldman
Stroke|January 21, 2017
Trends in Recruitment Rates for Acute Stroke Trials, 1990-2014William B Feldman, Anthony S Kim, Winston Chiong
JAMA Internal Medicine|December 3, 2019
Potential Medicare Savings on Inhaler Prescriptions Through the Use of Negotiated Prices and a Defined FormularyWilliam B Feldman, Jerry Avorn, Aaron S Kesselheim
Journal of Empirical Research on Human Research Ethics : JERHRE|April 20, 2022
Practicalities of Impracticability: An Interim Review of Randomized Controlled TrialsRoma Dhamanaskar, William B Feldman, Jon F Merz
The New England Journal of Medicine|September 26, 2022
Product Hopping in the Drug Industry - Lessons from AlbuterolOlivier J Wouters, William B Feldman, S Sean Tu
Pageof 11